Sector News

Nestlé, Coca-Cola and Unilever in final bidding war for GSK's Horlicks: report

October 3, 2018
Food & Drink

As several buyers pursue GlaxoSmithKline’s Indian consumer products business, the drugmaker has shortlisted Nestlé, Unilever and Coca-Cola for a second round of bidding, the Economic Times reports, citing people familiar with the discussions.

The business, which includes the drinks brand Horlicks, could fetch up to $4 billion, analysts have said. ET reported that the shortlisted companies are set to continue negotiations with GSK next week in London.

Other companies that reportedly shopped the deal include Kellogg, Mondelez, Danone, Reckitt Benckiser, PepsiCo and private equity firm KKR. The Telegraph last month reported Coca-Cola was preparing a multibillion-pound offer.

GSK in March said it was reviewing options for its 72.5% share of GlaxoSmithKline Consumer Healthcare Ltd., a public company listed on India’s exchanges. The sale would generate cash after GSK agreed to pay $13 billion for Novartis’ share in the two pharma giants’ consumer healthcare joint venture.

Despite its ongoing consumer sale process in India, GSK has stressed that it’s not backing away from the Indian market altogether. The drugmaker plans to back OTC and oral health brands in the country as well as invest in prescription drugs and vaccines, executives have said.

Meanwhile, in the U.S., GSK is cutting 650 jobs to reduce its cost base and reinvest the savings into new launches and R&D.

By: Eric Sagomowsky

Source: Fierce Pharma

comments closed

Related News

October 2, 2022

Drinktec 2022: In review

Food & Drink

In the lead-up to the world-famous Oktoberfest – which celebrates Bavarian tradition, beer and the festival spirit – Munich was already buzzing with activity by the time the doors opened to Drinktec 2022 on 12-16 September. The atmosphere was lively, with approximately 50,000 visitors from 169 countries in attendance.

October 2, 2022

Alan Jope to step down as Unilever CEO

Food & Drink

Unilever has announced CEO Alan Jope’s decision to retire from the company at the end of 2023, after five years at the helm. The announcement comes less than a year after a failed attempt by Unilever to buy GlaxoSmithKline’s consumer healthcare business and just months after activist investor Nelson Peltz joined the company’s board.

October 2, 2022

Lakeland Dairies names Colin Kelly as next group CEO

Food & Drink

Lakeland Dairies has announced that Colin Kelly will assume the role of group CEO following the retirement of Michael Hanley at the end of the year. Kelly will take up the position in January 2023, while Hanley will step down in December this year.